Drug Type Small molecule drug |
Synonyms M4K2286 |
Target |
Mechanism ALK2 inhibitors(Activin receptor type-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Intrinsic Pontine Glioma | Preclinical | CA | 18 Mar 2024 | |
Diffuse Intrinsic Pontine Glioma | Preclinical | CA | 18 Mar 2024 |